Gni Group Stock price
¥2,132.00
-943.00
30.67%
1M
-1,108.00
34.20%
6M
-280.00
11.61%
YTD
-383.00
15.23%
1Y
+203.00
10.52%
3Y
+480.00
29.06%
5Y
+1,582.00
287.64%
10Y
+1,845.33
643.72%
20Y
Tokyo,
Closing price Fri, Nov 13 2026
+109.00
5.39%
Powered by
ISIN
JP3386370005
Symbol
2160
Industry
AI Insights on Gni Group
Insights
How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
Is Gni Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,087 stocks worldwide.
Key metrics
Basic
Market capitalization
¥133.2b
Enterprise Value
¥114.6b
Net debt
positive
Cash
¥23.7b
Shares outstanding
55.8m
Valuation
P/E
negative
P/S | estimate
5.0 | 3.2
EV/Sales | estimate
4.3 | 2.8
EV/FCF | ex SBC
negative | -
P/B
3.3
Financial Health
Equity Ratio
60.1%
Return on Equity
-8.4%
ROCE
-2.5%
ROIC
-5.7%
Debt/Equity
0.1
Gni Group Stock Analysis
Unlock Scores for Free
Analyst Opinions
7 Analysts have issued a Gni Group forecast:
Analyst Opinions
7 Analysts have issued a Gni Group forecast:
Buy
86%
Hold
14%
Gni Group Events
Past Events
|
NOV
13
Q3 2026 Earnings Call
one day ago
|
Don't miss a Thing! We will send you all news about Gni Group directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 990 full-time employees. The company went IPO on 2007-08-31.
| Head office | Japan |
| CEO | Dr. Luo |
| Employees | 990 |
| Website | www.gnipharma.com |


